The migraine market is on the brink of significant growth, with projections indicating a steady increase in demand for innovative therapies. As of 2024, the market size stands at USD 6.0 billion, and by 2035, it is expected to reach USD 9.074 billion, reflecting a compound annual growth rate (CAGR) of 3.83%. This upward trajectory is largely attributed to the rising prevalence of migraine...